| |
| |
|
| Insider
Information: |
Schorno Dean L |
| Relationship: |
|
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
427,415 |
|
|
Indirect Shares
|
6,149 |
|
|
| Direct
Value |
$2,047,330 |
|
|
|
Indirect Value
|
$390,093 |
|
|
| Total
Shares |
433,564 |
|
|
| Total
Value |
$2,437,422 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
CFO |
2014-06-10 |
24,524 |
2014-06-10 |
6,149 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2024-02-05 |
402,891 |
2019-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RIGL |
Rigel Pharmaceuticals Inc |
EVP &Chief Financial Officer |
• – – |
2019-05-22 |
4 |
B |
$2.13 |
$106,544 |
D/D |
50,000 |
50,000 |
2.74 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP &Chief Financial Officer |
• – – |
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
128,908 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• • – |
2023-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
63,000 |
201,908 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• • – |
2023-02-02 |
4 |
S |
$1.66 |
$8,946 |
D/D |
(5,389) |
196,519 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• • – |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
209,000 |
415,519 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• • – |
2024-02-02 |
4 |
S |
$1.13 |
$6,327 |
D/D |
(5,601) |
409,918 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• • – |
2024-02-05 |
4 |
S |
$1.14 |
$8,011 |
D/D |
(7,027) |
402,891 |
0 |
- |
|
57 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
